Posizine 10 mg (Dapagliflozin)
Dapagliflozin 10mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.
MFDS item code 202004449 · Approved 2020.06.17
This product's status changed to Approval withdrawn on 2024.10.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be administered alone, or if sufficient blood sugar control is difficult, it may be used in combination with metformin, sulfonylureas, insulin, sitagliptin, etc. Such combination therapy is effective in cases where blood sugar is not controlled with multiple drug treatments. This medication stabilizes blood sugar levels and helps improve diabetes management.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medication is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medication is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when this medication is administered in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medication is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this medication. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medication may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Children under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.
This medication should not be administered to certain patients. For example, individuals allergic to the components or excipients of this medication, patients with type 1 diabetes, patients with diabetic ketoacidosis, and those with genetic conditions such as lactose intolerance should not use it. Additionally, patients undergoing dialysis should not take this medication. This medication should be used cautiously in patients with reduced fluid volume or poor kidney function, as it may lower blood pressure or temporarily alter blood creatinine levels, putting stress on the kidneys. Special caution is required for the elderly or those taking diuretics, and fluid status and kidney function should be carefully monitored before and after administration. Various side effects may occur while taking this medication. Commonly, genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, and diabetic ketoacidosis may occur. Genital and urinary tract infections may occur more frequently in women, and treatment is required immediately upon symptom onset. Hypoglycemia may occur more frequently when used with medications such as insulin or sulfonylureas, so caution is advised. This medication is not recommended for patients with severely impaired liver function, and those at risk of fluid volume reduction or hypotension should be particularly cautious. Additionally, serious metabolic disturbances such as ketoacidosis may occur, necessitating immediate consultation with a healthcare provider if symptoms arise. This medication may interact with other drugs, so those taking diuretics, insulin, or sulfonylureas should consult their doctor. It is advisable for pregnant or breastfeeding women not to use this medication. Regular blood sugar tests and kidney function tests are needed during treatment, as this medication can affect blood sugar control. Although it does not significantly impact driving or operating machinery, caution should be taken for potential hypoglycemic symptoms. The safety and efficacy of this medication in children have not been established, so it is not to be used in this population. In case of overdose, contact a medical facility immediately for appropriate treatment, as this medication may not be rapidly eliminated and may require professional management. Finally, this medication should be stored out of reach of children and kept in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture, at a safe temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication and prevent deterioration.
A yellow, biconvex diamond-shaped film-coated tablet
100 tablets/bottle, 8 tablets/box [8 tablets/Alu-Alu]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin 10mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Dapagliflozin 5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Dapagliflozin 10mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Korea Prime Pharma Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
IYUN Pharmaceutical Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Litepharmtech Co., Ltd.
Dapagliflozin 10mg
Tablet · Prescription medication
Samchundang Pharm. Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.